104 related articles for article (PubMed ID: 3753659)
1. Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment.
Brown T; Dawson AA; King DJ; Bullock I; Watt JL
Cancer Genet Cytogenet; 1986 Feb; 20(1-2):53-61. PubMed ID: 3753659
[TBL] [Abstract][Full Text] [Related]
2. The frequency of translocations after treatment for Hodgkin's disease.
Smith LM; Evans JW; Mori M; Brown JM
Int J Radiat Oncol Biol Phys; 1992; 24(4):737-42. PubMed ID: 1429098
[TBL] [Abstract][Full Text] [Related]
3. The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease.
Clay A; Swain A; Trounce JR
Br J Clin Pharmacol; 1977 Aug; 4(4):475-8. PubMed ID: 901740
[TBL] [Abstract][Full Text] [Related]
4. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
5. The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Brown T; Dawson AA; Bennett B; Moore NR
Cancer Genet Cytogenet; 1988 Nov; 36(1):89-102. PubMed ID: 3203299
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
7. The management of stage IIIA Hodgkin's disease.
Timothy AR; Sutcliffe SB; Lister TA; Wrigley PF; Jones AE
Int J Radiat Oncol Biol Phys; 1980 Feb; 6(2):135-42. PubMed ID: 7390887
[No Abstract] [Full Text] [Related]
8. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
9. The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years.
Dorreen MS; Wrigley PF; Laidlow JM; Plowman PN; Neudachin L; Tucker AK; Malpas JS; Stansfeld AG; Faux MM; Jones AE
Cancer; 1984 Dec; 54(12):2882-8. PubMed ID: 6548658
[TBL] [Abstract][Full Text] [Related]
10. Treatment failures and severe complications in children with Hodgkin's disease.
Armata J; Borkowski W; Kaczor Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):406-11. PubMed ID: 6169602
[TBL] [Abstract][Full Text] [Related]
11. Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
Oza AM; Ganesan TS; Dorreen M; Johnson PW; Waxman J; Gregory W; Lim J; Wright J; Dadiotis L; Barbounis V
Br J Cancer; 1992 Mar; 65(3):429-37. PubMed ID: 1558800
[TBL] [Abstract][Full Text] [Related]
12. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
13. Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Caggana M; Kelsey KT
Carcinogenesis; 1991 Nov; 12(11):2141-5. PubMed ID: 1934301
[TBL] [Abstract][Full Text] [Related]
14. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Diehl V
J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
[No Abstract] [Full Text] [Related]
15. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
16. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
17. Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
Dady PJ; McElwain TJ; Austin DE; Barrett A; Peckham MJ
Br J Cancer; 1982 Jun; 45(6):851-9. PubMed ID: 7093120
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
19. Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
Harding MJ; McNulty LJ; Paul J; Lee F; Brown A; Soukop M
Eur J Cancer; 1991; 27(8):1002-6. PubMed ID: 1832882
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
